Han Chong Toh, Deputy Chief Executive Officer at National Cancer Centre Singapore, shared on LinkedIn:
“ESMO – European Society for Medical Oncology 2026 an exhilarating success with over 40,000 attendees under blue madrid skies and warmest spanish hospitality.
New biologics cancer vaccines AI take centre stage. Much gratitude and a true privilege to be scientific track chair for investigational immunotherapy a journey that started almost 2 yrs ago as part of an amazing faculty – so much engaging crosstalk cross presentations high affinity compatibility zero toxicity.
Academic co-stimulation led by ESMO president fabrice andre, scientific chairs Yelena Janjigian James Larkin and a magnifico ESMO machinery helmed by the fab Federica Frigerio. Such depth breadth hygge joie de vivre la dolce vita in the ESMO family a globally inclusive village.
Hope springs eternal for cancer patients.”
Other articles featuring Han Chong Toh on OncoDaily.
